Filing Details
- Accession Number:
- 0001127602-18-024675
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-06 09:46:02
- Reporting Period:
- 2018-08-02
- Accepted Time:
- 2018-08-06 09:46:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238334 | Daniel Jonas | C/O Conmed Corp 525 French Road Utica NY 13502-5994 | Evp Legal Affairs,Gen. Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-02 | 2,000 | $32.93 | 20,347 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-02 | 1,221 | $80.40 | 19,126 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2018-08-02 | 1,560 | $44.90 | 20,686 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-02 | 1,106 | $80.40 | 19,580 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2018-08-02 | 12,000 | $51.30 | 31,580 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-02 | 9,133 | $80.40 | 22,447 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-08-02 | 4,000 | $79.73 | 18,447 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2018-08-02 | 2,000 | $0.00 | 2,000 | $32.93 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2018-08-02 | 1,560 | $0.00 | 1,560 | $44.90 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2018-08-02 | 12,000 | $0.00 | 12,000 | $51.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-06-01 | No | 4 | M | Direct | |
| 1,560 | 2024-06-01 | No | 4 | M | Direct | |
| 12,800 | 2025-02-27 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.54 to $80.13. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
- The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period.
Billionaire Hedge Funds
